Join our transatlantic panel of experts for an interactive, full-day virtual conference to be up to date with all the most exciting discoveries in immuno-oncology! During this unique online conference, the esteemed experts from Dana-Farber Cancer Institute/Gustave Roussy/Paris-Saclay University will review their latest clinical research and data covering a broad spectrum of immuno-oncology. We are pleased to announce that the keynote will be given by Professor William Kaelin, the 2019 Nobel Prize in Physiology or Medicine recipient.
DATE/TIME: Friday, May 13, 2022 | 8:30 EDT/ 14:30 CEST
Learn More & Register
Hello. My name is Tony Sherry and I'm the director of the Lank Center for genital urinary oncology at the Dana Farber cancer Institute in boston. I'm also the jerome and nancy Kohlberg chair and professor of medicine at Harvard Medical School. On behalf of the program committee. I would like to encourage you to join me for the confidence transatlantic exchanges in interventional oncology. This is a meeting gathering, expert faculty from the Dana Farber Cancer Institute and the institute Gustavo will see for interactive discussions on May 13 which is being brought to you with the assistance of Medscape Medical Affairs. The meeting here in boston is that inaugural scientific conference of a series of annual meeting named Dana Farber to stab you see days and oncology which we will be initiating with the support of the Law Institute survey last year despite the challenges that we all face. The program committee had a first version and vision of these transatlantic parks which led us to start this collaboration. During this one day meeting, our panel of expert faculty of scientists and physicians. Scientists from both centers will discuss the recent advances and future directions of immuno oncology. They will each focus on their most recent discoveries and results which arranged from basic to translational and clinical oncology. Why first the theme of immuno oncology for our first exchange? Well we know that immunotherapy has the potential for a chemotherapy free approaches to oncology meant harnessing our immune system in the management of cancers has the potential to change the way how our patients experience and live with castle. The program has been co created together with all the speakers, which you will see in this highly interesting and varied approaches to this theme. Thanks to this, we will cover a wide range of topics and emerging paradigms in the area of immuno oncology. So please join me and your peers for this first meeting, which will be streaming live on May 13th 2022 will be available on demand post event on Medscape dot com. I do look forward to seeing you here.
